前列腺癌近距离放疗联合外照射中加速与标准小 margins 放疗方案的随机试验:毒性结局与前列腺运动模式
一项随机试验纳入34例接受高剂量率近距离放疗(14.5 Gy × 1)联合外照射(3 Gy × 14)的前列腺癌患者,随机分配至外照射每周3次或5次,采用Raypilot实时追踪系统以3 mm margins 实施外照射。结果显示两组毒性无统计学显著差异;靶区位移在97.0%的治疗时间内<2 mm,在99.9%的活动治疗时间内<3 mm。
要点
- 加速组与标准组急性毒性无统计学显著差异。
- 靶区位移<2 mm占97.0%时间,<3 mm占99.9%活动治疗时间。
- 实时追踪系统下3 mm margin 在靶区正确勾画前提下 seems 可行且安全。
核心结论
- 加速放疗方案未发现急性毒性增加的证据。
- 在靶区正确勾画前提下,使用实时追踪系统时3 mm margin seems 可行且安全。
研究设计与样本
- 随机试验,纳入计划接受高剂量率近距离放疗(14.5 Gy × 1)联合外照射(3 Gy × 14)的前列腺癌患者。
- 2018年6月至2020年1月共纳入34例患者(中位年龄70岁),每组各17例,随机分配至外照射每周3次或每周5次。
- 外照射采用3 mm margins,使用Raypilot系统实时追踪分次内前列腺运动,连续监测3个维度。
- 主要终点为毒性,采用EORTC QLQ-C30和QLQ-PR25患者报告结局评估。
主要发现
- 两组间毒性无统计学显著差异。
- 靶区位移在97.0%的时间内<2 mm,在99.9%的活动治疗时间内<3 mm。
关键数值与推荐
- 高剂量率近距离放疗剂量为14.5 Gy × 1。
- 外照射剂量为3 Gy × 14。
- 外照射 margins 为3 mm。
- 靶区位移<2 mm占97.0%时间,<3 mm占99.9%活动治疗时间。
临床怎么用
- 使用实时追踪系统时,3 mm margin 在靶区正确勾画前提下 seems 可行且安全。
- 加速外照射方案(每周5次)未发现急性毒性增加。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Hypofractionated radiation therapy requires high accuracy in dose delivery to enable reduced treatment margins and minimize the dose to organs-at-risk. The purpose of this study was to evaluate whether accelerated (delivered 5 times per week) hypofractionated external beam radiation therapy (EBRT) can be performed without increased acute toxicity using a real-time tracking system. We also aimed to investigate patterns of intrafractional prostate movements. METHODS AND MATERIALS: Patients with prostate cancer planned for combined high dose rate brachytherapy (14.5 Gy × 1) and EBRT (3 Gy × 14) were included in this randomized trial to receive the EBRT part of the treatment either 3 or 5 times per week. EBRT was delivered using small margins (3 mm) using the Raypilot system for real-time tracking of intrafractional prostate movements. Movements were continuously monitored in 3 dimensions. Primary endpoint was toxicity that was assessed using patient-reported outcome measures through european organisation for research and treatment of cancer (EORTC) quality of life questionnaires QLQ-C30 and QLQ-PR25. RESULTS: During June 2018 to January 2020, 34 patients (median age 70 years) were included in the study of which 17 were randomized to each group. No statistically significant differences in toxicity were found between the study groups. Target displacement was <2 mm during 97.0% of the time and <3 mm during 99.9% of the active treatment time. CONCLUSIONS: We found no evidence of increased acute toxicity in patients who received accelerated treatment schedule. Provided that the target is properly delineated, a 3 mm margin seems to be feasible and safe when using a real-time tracking system.
引用
- Staby Olsén J, Valachis A, Johansson B, et al. A Randomized Trial on Accelerated Versus Standard Small-margin Radiation Schedule in Patients With Prostate Cancer Treated With Combined Brachytherapy and External Beam Radiation Therapy: Toxicity Outcomes and Patterns of Prostate Movement. Adv Radiat Oncol. 2025. PMID: 40161542. doi:10.1016/j.adro.2025.101737
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。